SRC and breast carcinoma: For example, it was found that knockdown of Src or treatment with Src kinase inhibitors downregulated the expression of Slug and vimentin but increased E-cadherin expression in breast cancer cells and head and neck squamous cell carcinoma (HNSCC) cells [29,30].